Thiruvananthapuram: R.P. Khandelwal, who currently holds the post of director (finance) of HLL Lifecare Limited (HLL), has been given the additional charge of its chair person and managing director. His elevation comes after Dr M. Ayyappan retiring last month as CMD of the 1966-founded Central ‘mini Ratna’ with an annual turnover of over Rs 1,000 crore and a diverse portfolio of contraceptives, pharmaceuticals and personal hygiene and hospital products, besides diagnostic services.
Mr Khandelwal, who joined HLL as director (finance) in May 2009, provides leadership to the company’s corporate finance division. Before joining the HLL, he was the director (finance) at Hindustan Insecticides Ltd. In his chequered career, he also spent 22 years in Steel Authority of India Ltd, heading its shares department and productively contributing to segments like materials management, techno-economics, finance, board and company affairs. He left SAIL as senior deputy director (finance) in charge of project finance and JV group.
A graduate in chemistry with MBA in finance from BIT Mesra (Ranchi), he is also the board member of Hindustan Latex Family Planning Promotion Trust (HLFPPT). He holds the professional qualifications of AICWA, ACS and LLB. He is a member of Institute of Cost Accountants of India and Institute of Company Secretaries of India.
Recognising his robust contribution as a professional in cost and management accountancy, he was bestowed with the award for the “outstanding contribution to profession” by the Institute of Cost Accountants of India (ICAI) in 2012. Currently, the group consists of seven entities: the flagship HLL Lifecare, HLL Biotech, HLL Infra Tech Services, LifeSpring Hospitals, Goa Antibiotics and Pharmaceuticals, HLFPPT and HLL Management Academy.
